Targeting Trop-2 as a Cancer Driver
Journal of Clinical Oncology · 10.10.2023 · 41 (29) · 4688-4692
DOI: 10.1200/jco.23.01207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.10.2023. Verfasst von Emanuela Guerra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, Italy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, Italy.
- Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti, Italy.
- Unit of Medical Genetics, Department of Biomedical Sciences-BIOMORF, University of Messina, Messina, Italy.
ORCID-Profile: Emanuela Guerra, Marco Trerotola, Saverio Alberti
Zitieren
APA
Guerra, E., Trerotola, M., & Alberti, S. (2023). Targeting Trop-2 as a Cancer Driver. Journal of Clinical Oncology, 41(29), 4688-4692. https://doi.org/10.1200/jco.23.01207
Vancouver
Guerra E, Trerotola M, Alberti S. Targeting Trop-2 as a Cancer Driver. Journal of Clinical Oncology. 2023;41(29):4688-4692. doi:10.1200/jco.23.01207
BibTeX
@article{Guerra2023,
author = {Guerra, Emanuela and Trerotola, Marco and Alberti, Saverio},
title = {Targeting Trop-2 as a Cancer Driver},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {29},
pages = {4688--4692},
doi = {10.1200/jco.23.01207}
}
EUVIMED